(Q39265787)

English

Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

chemoradiotherapy

0 references

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Steinbjørn Hansen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Kenneth F Hofland

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Morten Sorensen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Silke Engelholm

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Henrik P Schultz

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Aida Muhic

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Kirsten Grunnet

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Anders Ask

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Junia C Costa

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Charlotte Kristiansen

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Carsten Thomsen

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Hans Skovgaard Poulsen

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

23 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Acta Oncologica

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

53

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

939-944

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

The biology of VEGF and its receptors

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.879607

21 January 2018

A phase II trial with bevacizumab and irinotecan for patients with primary brain tumors and progression after standard therapy

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.879607

21 January 2018

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.879607

21 January 2018

Bevacizumab plus irinotecan in the treatment patients with progressive recurrent malignant brain tumours

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.879607

21 January 2018

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.879607

21 January 2018

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.879607

21 January 2018

Addition of bevacizumab to standard radiation therapy and daily temozolomide is associated with minimal toxicity in newly diagnosed glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.879607

21 January 2018

Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.879607

21 January 2018

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.879607

21 January 2018

Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.879607

21 January 2018

Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.879607

21 January 2018

Prognostic and predictive value of epigenetic silencing of MGMT in patients with high grade gliomas: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.879607

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.879607

21 January 2018

The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.879607

21 January 2018

A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.879607

21 January 2018

Identifiers

10.3109/0284186X.2013.879607

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24456504%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39265787&oldid=1566598977"